[
  {
    "ts": null,
    "headline": "Jim Cramer on Moderna (MRNA): “I’ve Been Against This Stock For So Long”",
    "summary": "We recently published a list of Jim Cramer Talked About These 13 Stocks. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against other stocks that Jim Cramer discusses. A caller asked what Cramer thought of Moderna, Inc. (NASDAQ:MRNA), and he said: “There’s gotta be some value in […]",
    "url": "https://finnhub.io/api/news?id=52b19cb5cc1ad2d37fe970a3f4563c77ab240d431b4abb3997293de434797511",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748273748,
      "headline": "Jim Cramer on Moderna (MRNA): “I’ve Been Against This Stock For So Long”",
      "id": 134717613,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "We recently published a list of Jim Cramer Talked About These 13 Stocks. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against other stocks that Jim Cramer discusses. A caller asked what Cramer thought of Moderna, Inc. (NASDAQ:MRNA), and he said: “There’s gotta be some value in […]",
      "url": "https://finnhub.io/api/news?id=52b19cb5cc1ad2d37fe970a3f4563c77ab240d431b4abb3997293de434797511"
    }
  },
  {
    "ts": null,
    "headline": "MRNA Seeks FDA Nod for Updated COVID-19 Vaccine",
    "summary": "Moderna files with FDA for updated Spikevax aimed at the LP.8.1 variant, which makes up 70% of U.S. COVID-19 cases.",
    "url": "https://finnhub.io/api/news?id=7d0d9271ac3d6a3a421e6a872b1506e621fb961f3940cea3465256106753f34f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748266860,
      "headline": "MRNA Seeks FDA Nod for Updated COVID-19 Vaccine",
      "id": 134717615,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna files with FDA for updated Spikevax aimed at the LP.8.1 variant, which makes up 70% of U.S. COVID-19 cases.",
      "url": "https://finnhub.io/api/news?id=7d0d9271ac3d6a3a421e6a872b1506e621fb961f3940cea3465256106753f34f"
    }
  },
  {
    "ts": null,
    "headline": "Veracyte: Upgrading To Neutral",
    "summary": "Veracyte's Q1 results beat expectations, with 18.2% revenue growth and non-GAAP EPS of $0.31 supported by a strong balance sheet and no long-term debt. Learn more on VCYT stock here.",
    "url": "https://finnhub.io/api/news?id=1ccf092bd03bcea3e93f478e3c0090b83c49b45fdb6e23b6e7864cffea959ae3",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748255567,
      "headline": "Veracyte: Upgrading To Neutral",
      "id": 134700372,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1330728771/image_1330728771.jpg?io=getty-c-w1536",
      "related": "MRNA",
      "source": "SeekingAlpha",
      "summary": "Veracyte's Q1 results beat expectations, with 18.2% revenue growth and non-GAAP EPS of $0.31 supported by a strong balance sheet and no long-term debt. Learn more on VCYT stock here.",
      "url": "https://finnhub.io/api/news?id=1ccf092bd03bcea3e93f478e3c0090b83c49b45fdb6e23b6e7864cffea959ae3"
    }
  },
  {
    "ts": null,
    "headline": "COVID Vaccine Makers Catch a Break in FDA Policy Shift",
    "summary": "Moderna is counting on revenue from newer mRNA vaccines, including a next generation Covid shot, to make up for falling sales. The post COVID Vaccine Makers Catch a Break in FDA Policy Shift appeared first on The Daily Upside.",
    "url": "https://finnhub.io/api/news?id=594a7e92e6193952e94c2c1c2151fad3bdd0d18e2500980399a72e922dafde63",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748255400,
      "headline": "COVID Vaccine Makers Catch a Break in FDA Policy Shift",
      "id": 134756389,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna is counting on revenue from newer mRNA vaccines, including a next generation Covid shot, to make up for falling sales. The post COVID Vaccine Makers Catch a Break in FDA Policy Shift appeared first on The Daily Upside.",
      "url": "https://finnhub.io/api/news?id=594a7e92e6193952e94c2c1c2151fad3bdd0d18e2500980399a72e922dafde63"
    }
  }
]